Daily Archives: February 1, 2016

Amorsa Therapeutics Selected to Present at Cavendish Global Health Impact Forum

Forum uniquely brings together leading family offices, their foundations and sovereign wealth fund representatives seeking impact investment, grant-giving, and philanthropy opportunities within health and life sciences Littleton, MA, Feb. 1, 2016 — Amorsa Therapeutics, a preclinical stage, neuropharmaceutical company, announced today it has been selected to present at the Cavendish Global Health Impact Forum taking place February 15th to February 18th at the Breakers in Palm Beach, Florida. The purpose of the Forum is to help family offices and foundations develop and implement their individual pro-social impact investing, grant-giving, and philanthropy programs within health and the life sciences. To accomplish More